Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients

Concurrent chemoradiation therapy (CCRT) is the treatment of choice for locally advanced non-small cell lung cancer (LA-NSCLC). Several clinical trials that combine programmed cell death 1 (PD-1) axis inhibitors with radiotherapy are in development for patients with LA-NSCLC. However, the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimoto, Daichi, Uehara, Keiichiro, Sato, Yuki, Sakanoue, Ichiro, Ito, Munehiro, Teraoka, Shunsuke, Nagata, Kazuma, Nakagawa, Atsushi, Kosaka, Yasuhiro, Otsuka, Kojiro, Imai, Yukihiro, Hamakawa, Hiroshi, Takahashi, Yutaka, Kokubo, Masaki, Tomii, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595796/
https://www.ncbi.nlm.nih.gov/pubmed/28900290
http://dx.doi.org/10.1038/s41598-017-11949-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595796/
https://www.ncbi.nlm.nih.gov/pubmed/28900290
http://dx.doi.org/10.1038/s41598-017-11949-9

Ejemplares similares